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The culture of live pancreatic tissue slices is a powerful tool for the interrogation of
physiology and pathology in an in vitro setting that retains near-intact cytoarchitecture.
However, current culture conditions for human pancreatic slices (HPSs) have only been
tested for short-term applications, which are not permissive for the long-term, longitudinal
study of pancreatic endocrine regeneration. Using a culture system designed to mimic the
physiological oxygenation of the pancreas, we demonstrate high viability and preserved
endocrine and exocrine function in HPS for at least 10 days after sectioning. This extended
lifespan allowed us to dynamically lineage trace and quantify the formation of insulin-
producing cells in HPS from both non-diabetic and type 2 diabetic donors. This technology is
expected to be of great impact for the conduct of real-time regeneration/developmental
studies in the human pancreas.
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The identification of methods to stabilize, section and cul-ture slices of live pancreatic tissue1,2 represented a quali-tative leap in our ability to study the biology and function
of the pancreas. This in vitro setting preserves much of the
cytoarchitecture of the organ, allowing for the dynamic study of
islet physiology and the interactions between endocrine, exocrine,
neural, vascular and immune cells in their anatomical context3–7.
Since this method is less damaging to the tissue than those used
to isolate islets or exocrine tissue, the studied phenomena are
more likely to approximate the native biology of the organ. As
originally reported, the method entails the retrograde injection of
low melting point (LMP) agarose through the major pancreatic
duct of mice1,4. LMP hardens and stabilizes the pancreas, which
can be subsequently extracted, further embedded in agarose and
sliced with a vibratome. Slicing techniques have recently been
adapted to human pancreas8,9. These reports have attracted
widespread interest, especially owing to simultaneous initiatives
such as that of the Network of Pancreatic Organ Donors with
Diabetes (nPOD) program, to obtain and distribute live pan-
creatic tissue from type 1 diabetes (T1D) patients. The use of
slicing techniques on those precious samples has the potential to
unveil a wealth of information on the dynamic processes of
autoimmunity and regeneration in T1D. However, current set-
tings (which entail the culture of slices atop transwell inserts)
have not been tested for long-term culture, a sine qua non
requirement for the study of regeneration. Based on our previous
experience with human isolated islets10 and embryonic-stem cell
(hESc)-derived β-like cells11,12, we anticipated that improper
oxygenation might induce hypoxia and thus compromise HPS
viability and function over several days of culture. This was
confirmed experimentally through metabolic and viability assays.
Therefore, we sought to identify improved ways to culture HPSs
long-term. Using a perfluorocarbon (PFC)-based system designed
to enhance oxygen transfer to three-dimensional tissues10,11,13, as
well as a refined medium composition, herein we present evi-
dence that HPSs from both healthy and T1D/T2D donors survive
and exhibit normal function beyond 10 days of culture. This
extended lifespan was sufficient to detect, longitudinally track and
quantify β-cell regeneration in slices from transgenic mice14
as well as HPSs from both healthy and T2D human donors co-
transduced with adenoviral vectors carrying a reporter and an
insulin lineage tracer. The latter approach opens the door to the
study of human pancreatic remodeling and regeneration in an
in vitro setting that largely preserves the compartment distribu-
tion, cell-to-cell interactions and niches of the native organ.
Results
Mathematical modeling of oxygen diffusion in HPSs. To pre-
dict oxygenation patterns across 120 µm-thick HPSs, we per-
formed 2D diffusion reaction modeling of oxygen distribution
using COMSOL v5.3 (COMSOL Inc, Burlington, MA) as
described10,11. A parametric sweep of oxygen consumption rate
(OCR) (1.0–5.0 × 10−2 mol/m3 s−1) unique to pancreatic tissue15
was performed. An estimated oxygen consumption rate (OCR) of
0.03 mol/m3 s−1 (average for islets and acinar tissue15) was used
(Fig. 1). Two culture settings were modeled: standard transwell1
and PFC-based dishes10. While an air-liquid interface above
the tissue is acceptable for short-term analyses, the medium
evaporates quickly. Studies requiring survival for longer than a
few hours require the slices to sit atop a liquid-permeable
membrane and be surrounded by medium both from the top and
the bottom (Fig. 1a, left). Unlike in conventional transwells, in the
PFC setting, slices rest atop a liquid-impermeable PFC-based
membrane10,11,13 that provides direct contact with oxygen from
underneath (Fig. 1a, right), whereas the tissue is completely
covered by medium. Figure 1b shows the predicted oxygenation
patterns of transwell- and PFC-cultured slices throughout 24 h
when incubated at atmospheric O2 concentration (21%). Oxygen
partial pressure (pO2) (mmHg) in each setting is represented in a
color scale ranging from blue (lower) to red (higher). A pO2
of <0.1 mmHg was considered anoxic (represented as white
regions), as described for islets and acinar tissue10,15–20.
The models depicted in Fig. 1b, c and Supplementary Movies 1, 2
predict that anoxia will appear in transwell-kept slices as early as
16 h after their placement in culture, with a precipitous drop in
core oxygenation immediately afterwards (Fig. 1c). Additional
estimations of the anoxic volume for a parametric sweep of OCRs
are indicated in Fig. 1d. Some degree of anoxia is predicted to
emerge in PFC-cultured HPSs at higher-than-average OCRs, but
the relative volume of anoxic tissue is always significantly lower
than that modeled for transwell-cultured controls. While we
cannot exclude that other oxygen concentrations may result in
even better outcomes, our models show that 21% is sufficient
to prevent the formation of anoxic regions over 24 h. Therefore,
for the sake of convenience, we kept an atmospheric O2 con-
centration for all experiments.
We also confirmed experimentally the prediction that HIF-1α,
which is upregulated in low oxygen concentrations, had
significantly higher expression in transwell- vs. PFC-cultured
slices after 24 h of culture (Fig. 1e).
Metabolic differences in PFC-cultured vs. control HPSs. The
above mathematical predictions suggest that HPSs cultured in
transwells may suffer the consequences of oxygen deprivation,
amongst which a switch from oxidative phosphorylation to
anaerobic glycolysis has been reported21. Since glycolysis is a less
efficient means to generate energy (2 ATP/molecule of glucose vs.
~30 by oxidative phosphorylation), we further hypothesized that
transwell-cultured HPSs would also exhibit a higher glucose
consumption rate (GCR) compared to those cultured on PFC. To
test these hypotheses, we proceeded to culture HPSs in transwells
or PFC dishes (n= 3 independent donors). Medium aliquots
were taken every 24 h (just before daily changing) for 10 days,
and glucose consumption, lactate production and osmolarity
measured on a Beckman Coulter Vi-CELL MetaFLEX (Brea, CA).
Lactate production (an indirect measurement of glycolytic
metabolism) was significantly higher in the transwell group vs.
PFC, both overall (AUC p-value= 0.03) and at every time point
analyzed (Fig. 1e). Also, as predicted, HPSs cultured in transwells
displayed a higher glucose consumption rate than their PFC
counterparts at every time point after day 1 (AUC p-value= 0.04)
(Fig. 1f), an observation that likely reflects a heightened need of
sugar to keep up with energy demands in partially anaerobic
conditions.
We further measured ATP production for n= 3 slices cultured
in either TW or PFC for 10 days. The average ATP production in
transwell-cultured slices was 21.9 ± 8.3 pm/μg of protein, com-
pared to 57.7 ± 42.5 pm/μg in those cultured in PFC, which is
statistically insignificant (p-value= 0.06) (±, standard deviation,
two-tailed t-test). However, the production of ATP (pm)/μg of
glucose, normalized by μg of protein, was 38.5 in the PFC group
vs. 6.8 in the TW group (a ~6-fold increase). Thus, while both
groups have comparable production of ATP, slices cultured in
PFC dishes generate it with six times less glucose. Figure 1g shows
the higher relative uptake of the fluorescent D-glucose analogue
2-[N-(7-nitrobenz-2-oxa-1,3-diazol-4-yl)amino]-2-deoxy-D-glu-
cose (2-NBDG) by slices cultured in transwells vs. those in PFC
during a 10-minute incubation. Quantification of the mean
fluorescence intensity (MFI)/DAPI+ cells in both groups (0.53 ±
0.15 for the transwells vs. 0.075 ± 0.06 in PFC, a 7-fold increase)
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Fig. 1 Enhanced oxygenation of human live pancreatic slices prevents anoxia and preserves oxidative phosphorylation. a Diagram outlining the
perfluorocarbon (PFC) membrane AirHive cell culture dish compared to a transwell dish. PFC dishes are selectively permeable to gases but not liquids.
Therefore, medium can be added from the top while air is preferentially transferred directly from the bottom. Graphics partially done with BioRender.
b COMSOL modeling of oxygen partial pressure across human pancreatic slices cultured in transwells (left) or PFC membranes (right) over a 24 h period.
Spectral scale ranges from high (red) to low (blue) oxygen partial pressure. Anoxic areas are in white. c Partial pressure of oxygen within the core of the
slice as a function of time. The dashed threshold represents anoxia. d Total anoxic volume of PFC- (red) and transwell- (blue) cultured slices modeled
against increasing oxygen consumption rates. e HIF-1α protein level determination in transwell- vs. PFC- cultured slices after 24 h of culture (n = 5
biologically independent samples from individual donors). Two-tailed t-test: *p-value= 0.0304. f Lactate production rate of PFC- (red) and transwell-
(blue) cultured slices as a function of time. n= 3 biologically independent samples from individual donors. Multiple two-tailed t-tests: **p-val1day= 0.0083,
**p-val2days= 0.0037, **p-val3days= 0.0056, *p-val4days= 0.0319, *p-val5days= 0.0357, *p-val6days= 0.0111, *p-val7days= 0.0192, **p-val8days= 0.0092,
***p-val9days= 0.0004, ***p-val10days= 0.0009. g Glucose consumption rates of PFC- (red) and transwell- (blue) cultured slices as a function of time.
n= 3 biologically independent samples from individual donors. Two-tailed t-tests: **p-val7day= 0.0063, *p-val8days= 0.0167, *p-val9days= 0.0244,
*p-val9days= 0.0343. h Representative immunostaining of 2-NBDG uptake (green) during a 10-min incubation of human pancreatic slices cultured in
transwells (top) or PFC dishes (bottom), reflecting the higher relative uptake of glucose of the former. Red: Propidium Iodide (PI), indicative of cell death.
Blue: DAPI. Scale: 100 μm. b–d represent theoretical computational modeling and have no error bars. In e, data are presented as mean ± S.E.M; in f, g, as
mean ± SD. Each n further represents the mean of three technical replicates. Source are provided in the Source Data file.
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confirms that the differences between the two groups are
statistically significant (two-tailed t-test, p-value= 0.02). The
lower glucose uptake in the PFC group was not due to lower
viability of the tissue. In fact, the opposite is true, as there was a
2.6-fold increase in the ratio of propidium iodide (PI, cell death
marker): DAPI in the transwell (0.40 ± 0.04) vs. the PFC (0.14 ±
0.06) group (two-tailed t-test, p-value= 0.007). This observation
further supports the hypothesis that slices cultured in transwells
require higher glucose uptake.
While carbon isotope techniques would be necessary to
conclusively demonstrate metabolic changes, our data collectively
suggest that culture of HPSs in PFC membranes preserves the
usage of physiological oxidative phosphorylation as a primary
source of energy over an extended period.
Long-term viability of HPSs cultured on PFC-based mem-
branes. Decreased viability and tissue degradation are expected
outcomes of sub-optimal oxygenation. We hypothesized that
PFC-mediated enhanced oxygenation, coupled with proteolytic
enzyme inhibition, would improve the overall long-term viability
of HPSs vs. standard culture. To test this, we proceeded to culture
HPSs from n= 5 independent (non-T1D) donors. (demographics
in Supplementary Table 1). For each donor, n= 20 slices were
assigned either to PFC (n= 10) or transwell (n= 10) groups.
Consecutively cut slices were split between the two groups to
minimize the impact of potential regional variations. Figure 2a
shows live (green)/dead (red) imaging of a representative freshly
sectioned slice, typically >80% viable (Fixed Viability Dye,
Thermo-Fisher Scientific, Waltham, MA). A dead (fixed) slice
is stained for comparison in Fig. 2b. Following extended culture,
the viability (percentage of live/dead cells) (Fig. 2c–e, Supple-
mentary Fig. 1b) and cross-sectional area (reflective of overall
tissue integrity) of HPSs cultured in transwells are lower than
those observed in PFC (Fig. 2f–g, Supplementary Fig. 1c). Slices
from a T1D donor (Supplementary Table 1) also exhibit the same
behavior when kept in either culture setting, as indicated in
Fig. 2h–i. To further characterize the effects of culture conditions
on HPSs, we performed immunofluorescence assays for endo-
crine and exocrine markers. Figure 2j shows rounded islets and
well-preserved islet endocrine cell types both at day 0 and at day
10 of PFC culture. However, those of HPSs kept in transwells
have less-defined boundaries (Fig. 2j).
All the quantified endocrine cell types were positive for their
respective hormone and DAPI, suggesting nuclear integrity. The
relative proportion of β-, α- and δ-cells remains unchanged
(Fig. 2k) in all conditions. This observation, coupled with the
overall reduction in cross-sectional surface (Fig. 2d, e) and
smaller islet area in transwells at 10 days (Fig. 2l) suggests that
progressive cell death in transwells occurs similarly across all cell
populations. Otherwise, the proportion of endocrine cells vs. all
the cells would be altered in transwells at day 10. Furthermore,
the relative abundance of Ki67-positive cells is similar in both
groups at day 10, with most proliferative cells observed in the
exocrine compartment (Supplementary Fig. 2a). Therefore,
culture in PFC dishes does not induce apparent changes in cell
turnover throughout a 10-day period.
Examination of key β-cell transcription factors NKX6.1 and
PDX1 at day 10 indicates that their expression is stronger in PFC
than transwell conditions (Supplementary Fig. 2b, c). While no
differences in amylase signal were apparent at low magnification
between day 0 and day 10 on either condition (Fig. 2m), higher
magnification images show that PFC-cultured slices have well-
preserved E-cadherin ultrastructure and display the typical
concentration of granules in the apical region of the cells
(Supplementary Fig. 2d, bottom). In contrast, slices cultured for
10 days in transwells have less-defined E-cadherin and acinar
morphology, with more diffuse amylase staining (Supplementary
Fig. 2d, top). This resolution was insufficient to detect potential
ultrastructural changes such as increase vacuole formation, basal
membrane abnormalities or junctional complex disruption.
qRT-PCR was conducted to test whether the expression of key
endocrine and non-endocrine genes was affected by long-term
culture in PFC- vs. transwell-cultured slices. As shown in
Supplementary Fig. 3, all the examined markers are upregulated
in PFC vs. transwells, further suggesting that the former preserves
better the integrity and function of HPSs.
Enhanced oxygenation supports extended function in HPSs.
The claim that HPSs sustain function throughout long-term
culture must be substantiated by functional assays for both the
endocrine and exocrine compartments. To do so, we measured
dynamic glucose-responsive insulin secretion (perifusion) and
glucose-mediated calcium imaging (both for endocrine activity),
as well as carbachol (CCh)-mediated release of digestive enzymes
indicative of acinar function. Figure 3a shows the pattern of
glucose-dependent insulin release (perifusion assay) in live slices
shipped from nPOD’s Gainesville laboratory (day +1S, one day
after sectioning, shipped; black), day +10 transwell (blue) and
day +10 PFC (red) islet-containing HPSs from n= 3 indepen-
dent donors. Perifusion charts for each donor are shown in
Supplementary Fig. 4. Figure 3d presents the analysis of HPSs
from a short-term T1D donor. Stimulation indices (SI) normal-
ized to baseline are in the Y-axis, with areas under the curve
(AUC) values in Fig. 3b, c (for non-diabetic donors) and Fig. 3e, f
(for the T1D donor).
All three groups (day +1S, day +10 transwell and day +10
PFC) exhibit glucose-stimulated responsiveness, although typical
biphasic responses were not observed. However, in comparison
with the PFC group, acute (i.e., shipped from nPOD) and
transwell groups showed decreased insulin secretion at 16 mM
glucose and 30 mM KCl stimulation. SIs were higher in PFC than
in transwells, and differences were statistically significant
(Fig. 3c).
Interestingly, acute samples (day +1S) normally had poorer
glucose responsiveness than those analyzed at day 10, which may
reflect shipment stress. This mirrors the reduction of islet
function immediately after isolation. In fact, islets are typically
allowed to rest for 24–48 h prior to the conduct of functional
assays, a period during which they deactivate stress signaling
pathways22,23. To test whether resting the slices for 24 h after
being subjected to stress would lead to functional recovery, we
conducted additional experiments on n= 3 new donors. In this
case, HPSs were generated in-house and perifused immediately
after slicing (day 0), after 24 h recovery (day +1) and then at day
+10 (transwells or PFC dishes). We hypothesized that day 0
HPSs would be stressed in the perisectioning period, thus having
poorer responses than those allowed to rest an additional day.
This hypothesis proved correct, as evidenced by a significant
rebound in the SI of HPSs rested for 24 h (Fig. 3g–i). Of note, day
0 responses in this setting are roughly equivalent to those
observed at day +1S in Fig. 3a, suggesting that both forms of
stress (shipping and slicing) have a deleterious, yet transient effect
on function. The glucose responsiveness of slices in PFC was
higher than that recorded in the transwell group at day 10, but in
this particular set of experiments (unlike in the previous one) the
differences were not statistically significant. This is probably due
to the high donor-to-donor variability, as shown in Supplemen-
tary Fig. 4b (individual donor perifusions) and Supplementary
Fig. 3 (qRT-PCR). All the experiments subsequently presented
showing acute measurements were conducted on rested slices.
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Fig. 2 Human pancreatic slices remain viable after extended culture. a Representative immunostaining showing tissue viability at the time of tissue slicing,
showing live (green) and dead (red) regions. Scale: 500 µm for all panels. b Immunostaining of control fixed slice showing only dead cells. Scale: 500 µm.
c Immunostaining showing slice viability assessments after 10 days of culture in either transwells or PFC dishes. Necrotic zones in transwell-cultured slices are
highlighted in magnified panel. Overt necrosis, in contrast, is not apparent in PFC-cultured HPSs. Scale: 500 µm. Magnified insets: 200 µm. For a–c: n= 5
biologically independent samples from individual donors. d Quantitative measurement of viable cell percentages in PFC (red)- and transwell (blue)-cultured
slices over a period of 10 days. Shaded area shows mean ± SD. e Bar plots showing cellular viability of either culture setting at day 5 and 10 post-slicing. Two-
tailed t-test: **p-val10days=0.002. f Slice cross-sectional area of slices kept in either culture condition for 10 days in culture. Shaded area shows mean ± SD.
g Individual bar plots showing slice cross-sectional area at days 7, 14, and 21 post slicing. Two-tailed t-test: **p-val14days=0.0036, ****p-val21days=0.000087.
For d–g: n= 4 biologically independent samples from individual donors. h Viable cell percentages of PFC- and transwell-cultured T1D donor slices over a period
of 10 days (n= 1 sample from an individual donor). i Slice cross-sectional area in either culture condition over 10 days of culture (T1D donor) (n= 1 sample from
an individual donor). j Immunofluorescence images showing expression of representative endocrine markers (INS insulin, white; GCG glucagon, red; and SST
somatostatin, green) within islets of slices at day 0 and cultured for 10 days in either transwells or PFC dishes. Scale for all panels: 500 µm; 100 µm for insets.
k Dot plot showing the distribution of endocrine cells in islets at day 0 and after 10 days of culture (PFC and transwells). l Dot plot showing the cross-sectional
area of islets at day 0 and after 10 days of culture (PFC and transwells). Two-tailed t-test: *p-valD10 (PFC)-D10 (TW)=0.0107. For j–l: data from n= 10 biologically
independent samples from individual donors. m Immunostaining showing insulin (INS, white) and representative exocrine markers (cytokeratin-19, CK-19, red;
and amylase, AMY, green) within slices at day 0 and after 10 days of culture (PFC and transwells). Blue, DAPI counter-staining. n= 10 biologically independent
samples from individual donors. Scale: 500 µm; 100 µm for insets. For d–i, k, and l, data are presented as mean ± SD. Each n further represents the mean of
three technical replicates. * p < 0.05; **p < 0.01; ***p < 0.005. Source are provided in the Source Data file.
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Figure 3j–l also shows dynamic glucagon secretion with glucose
stimulation. Although glucagon responsiveness is more difficult
to measure in HPSs due to the smaller number of alpha cells in
each sample, the rapid peak detected immediately after 1 mM
(low) glucose in the PFC group (Fig. 3j, red trace) is physiological,
unlike the delayed one observed in long-term transwell-cultured
HPSs (Fig. 3j, blue trace).
As Ca2+ imaging reflects β-cell activity24, we set out to
determine whether HPSs cultured for 10 days in either condition
exhibited changes in cytoplasmic Ca2+ concentration in response
to glucose stimulation, using the calcium indicator Fluo-4AM.
This technique allows to measure β-cell stimulation in response to
secretagogues such as 16.7 mM glucose or 30mM KCl (Fig. 3m, n
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respond (increased cytoplasmic Ca2+) to 16.7 mM glucose as well
as 30mM KCl in HPSs cultured for 10 days atop both transwells
and PFC membranes. KCl responses were not significantly
different between day 10 PFC- and transwell-cultured HPSs.
However, only PFC-cultured HPSs showed a significant difference
between baseline (3 mM) and stimulation concentrations
(16.7 mM) of glucose (Fig. 3o–p). We found β-cells to be
synchronous and oscillatory in both groups, without disruption
in coupling. Overall, pulses in cultured transwell-cultured slices
during 16.7 mM glucose stimulation were weaker than those in
PFC, but the results were not significantly different.
Exocrine cells respond to acinar-specific secretagogues such as
carbachol (acetylcholine agonist) and cholecystokinin25. In this
respect, we observed that exocrine cells in HPSs responded to
both (Fig. 3q–u, Supplementary Movie 4) without depolarization
by KCl (Fig. 3s), which is typical of endocrine cells26. Acinar
activity was also synchronized during carbachol stimulation.
Long-term HPS culture enables β-cell regeneration studies. To
establish proof of principle that extended culture of HPSs could
be used to study regeneration, we generated slices from a trans-
genic mouse (INSCremTmG)14 where insulin-producing cells are
labeled in green (EGFP), whereas the remaining cells are red
(mTomato) (Fig. 4a). This mouse has been used to study whether
β-cell neogenesis occurs from pre-existing β-cells or from non-
β-cells14. In this model, if new β-cells arise from pre-existing
ones, they will remain green. However, when a non-β-cell (e.g., a
progenitor, red) begins to express the insulin promoter, a Cre-
mediated recombination event leads to the excision of mTomato
and the expression of EGFP. There is a window during which the
mTomato protein has not been degraded yet but EGFP is already
expressed. Hence, the transient yellow (red+ green) color of
these cells can be used to identify β-cell neogenesis14.
BMP receptor agonists have been shown by our group to
induce the activation of progenitor-like cells residing in the major
ductal tree of the human pancreas27,28. Mirroring the experi-
mental design previously used with human non-endocrine
pancreatic tissue27 as well as sorted progenitor-like cells28, we
hypothesized that stimulation with a BMP receptor agonist,
followed by withdrawal thereof, would result in detectable β-cell
neogenesis in pancreatic slices. If new β-cells were to appear from
non-β-cells (e.g., progenitors), we would observe the conversion
of red into green cells. To test this hypothesis, slices were
generated from 6-8-week-old INSCremTmG mice, placed in PFC
dishes as previously described for HPSs, and treated for 5 days
with 100 ng/ml of BMP-7. Control slices received vehicle instead
of BMP-7. From day 6–9, BMP-7 was no longer administered. As
shown in Fig. 4b, newly formed insulin+ cells were observed
starting at day 9 in regions that had been previously devoid
of green (insulin) signal. No such occurrence was detected
in controls. Figure 4c presents another similarly designed
experiment using a BMP-7-like agonist, THR-12327,29. In this
case, green cells were detected from day 7, mostly in a region
corresponding to a large pancreatic duct.
To see whether we could replicate this model in non-transgenic
mice, we co-transduced pancreatic slices from CD-1 (wild-type)
mice with adenoviruses carrying the reporter construct CMV-
loxP-dsRED-loxP-EGFP (kindly given by P. Ravassard) and a rat
insulin promoter (RIP)-driven Cre recombinase (Fig. 4d). We
predicted that doubly transduced non-β-cells would be tagged red
and pre-existing β-cells would be tagged green. As in the previous
transgenic setting, an additional prediction was that doubly
transduced insulin+ cells arising from non-β-cells would be
transiently tagged red with decaying dsRED and permanently
green with newly produced EGFP (transient yellow). We treated
slices with BMP-7 as above. In all, 24 h after the double
transduction, islets were labeled green, as shown in the lower-
right inset of Fig. 4e. The formation of new insulin-expressing
cells from non-β-cells was confirmed in several regions of the
slices, normally associated to ductal areas, where groups of red
cells progressively transitioned to green following the treatment
with and subsequent withdrawal of BMP-7 (Fig. 4e). Red and
green signal could be readily monitored and quantified as a
function of total slice area longitudinally. When this experiment
was repeated using slices treated with the β-cell toxin alloxan,
control (non-BMP-7-treated) slices displayed virtually no green
signal throughout (Fig. 4f–h). As an additional internal control,
non-alloxan-treated slices (dashed-green line, Fig. 4h) exhibit
readily detectable green signal (corresponding to islets). The red
signal, corresponding to reporter-transduced slices, was similar
for all the experiments (Fig. 4g), indicating no aberrant
transduction efficiency due to alloxan treatment. However, when
the slices were treated with BMP-7, green signal was progressively
detected after alloxan administration, demonstrating new
insulin+ cell formation (Fig. 4i–k). Partially confirming the β-cell
Fig. 3 HPSs retain function after extended culture. a Perifusion of HPSs after high glucose (16.7 mM, 16 G) and KCl (30mM) stimulation. X-axis: time/
[Glucose]; Y-axis: SI Stimulation Index. Black: acute, day + 1S; red: PFC, day 10; blue: day 10 transwell. b Area under the curve (AUC) at 1–10 min (3 mM
glucose/baseline) (n= 3). c Left to right, AUC at 10–32min (16.7 mM, high glucose); 32–50min (1 mM, low glucose); and 50–60min (KCl depolarization).
a–c: n= 3 biologically independent samples from individual donors). One-way ANOVA post hoc Tukey HSD: *p-val16.7mM[D1 (acute)-D10 (PFC)]= 0.0362,
*p-val1mM[D1 (acute)-D10 (PFC)]= 0.0266, *p-valDepolarization[D1 (acute)-D10 (PFC)]= 0.0368. d Perifusion of T1D HPSs after high glucose and KCl stimulation.
Y-axis, SI. e AUC at 1–10 min (3 mM glucose). f Left to right, AUC as in c (n= 1 sample from an individual T1D donor). g Perifusion of HPSs from additional
donors after high glucose and KCl stimulation. Traces show responses at day 0 (immediately after slicing; green), d+ 1 (after a 24 h rest; black) as well as
day + 10 in transwells (blue) and PFC (red). Y-axis, SI. h AUC at 1–10 min (3 mM glucose). i Left to right, AUC as in c. One-way ANOVA post hoc Tukey
HSD: **p-val16.7mM[d0-d1]= 0.0047, *p-val1mM[d0-d1]= 0.0023. g–i: n= 3 biologically independent samples from individual donors. j Glucagon perifusion of
HPSs after stimulation with high glucose and KCl. Y-axis, SI. k AUC at 1–10min (3 mM glucose). l Left to right, AUC as in c. j–l: n=3 biologically
independent samples from individual donors. m Representative microphotograph of islet (backscatter) in a PFC-cultured slice at day 10, loaded with
Fluo-4-AM. Right panels: stimulation with 30mM KCl. Arrows point at three endocrine cells. n Traces of Ca2+ responses in cells after KCl stimulation,
color-coded to those indicated inm. o Trace of β-cells responding to high glucose and KCl stimulation. p AUC of Ca2+ responses after high glucose and KCl
stimulation. m–p: n= 3 biologically independent samples from individual donors. q Representative microphotograph of exocrine tissue upon stimulation
with carbachol (10 µM). Arrows point at three acinar cells. r Color-coded traces for carbachol stimulation of the cells in q. s Traces of cells exposed to KCl
after responding to carbachol, indicating non-endocrine phenotypes. t Left, amylase secretion after 10 pM CCK8 stimulation. Middle, AUC for 3 mM
glucose/baseline stimulation. Right, AUC for 10 pM CCK8. q–t: n = three biologically independent samples from individual donors. Two-tailed t-test:
*p-val3mM[Acute-d10TW]= 0.0307, ****p-val21days= 0.0450. u Left, amylase secretion after 10 µM carbachol stimulation. Middle, AUC for 3 mM glucose/
baseline. Right, AUC for 10 µM carbachol (n= 3). For a–c, g–l, and o data are presented as mean ± SEM, while for p, t, u data are presented as mean ± SD.
n= 1 chamber in d–f, hence no error bars. Each n further represents the mean of three technical replicates (three slices in one chamber in case of a–l, t–u).
*p < 0.05; **p < 0.01; ***p < 0.005. Source data are provided in the Source Data file.
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Fig. 4 Tracking of β-cell regeneration in murine pancreatic slices. a Representative microphotograph of murine pancreatic slices from Ins2-Cre.mTmG
mice, with EGFP+ insulin-producing cells (green) and all other cells tdTomato+ (red). An islet and adjacent duct are magnified in the inset. Scale 300 µm.
b Following 5 days of BMP-7 stimulation, removal thereof leads to insulin+ cell formation at d9. Scale 300 µm (magnified insets: 50 µm). c Representative
microphotograph of murine slices from Ins2-Cre.mTmG mice treated for 7 days with THR-123. Green arrow shows a pre-existing islet. After THR-123
removal, new insulin+ cells appear across the slice. Higher magnification confocal imaging of the same region (lower panel) shows new insulin+ cells
sprouting from ducts. Scale 200 µm; magnified panel: 100 µm. d Reporter strategy involving the co-transduction with adenoviral RIP-Cre tracer and lox/
dsRED/lox-EGFP reporter. Below are predicted outcomes depending on cell identity. e Representative microphotograph of CD1 mice-derived slices co-
transduced as in d. BMP-7 is added for 5 days and then withdrawn. D1-d8 images show progressive appearance of insulin-expressing cells (green) from
insulin– cells through an intermediate yellow (red+ green) stage. Pre-existing islet-resident β-cells are EGFP-tagged within the first 48 h of transduction, as
shown in d1 inset. Scale 50 µm. f Longitudinal imaging of CD1 mice-derived pancreatic slices transduced as in d. Alloxan was used to ablate β-cells at d1. No
BMP-7 was added. Scale 500 µm. g Expression of dsRED protein in transduced control slices over 7 days in alloxan-treated (+) and untreated (−) slices.
h EGFP expression and co-localization of EGFP+ dsRED in co-transduced alloxan-treated (+) and untreated (−) slices over 7 days. i Representative
microphotograph of CD1 mice-derived slices co-transduced as in d. Slices were also treated with alloxan to ablate β-cells and subsequently exposed to
BMP-7 from day 2 to day 4. Scale 500 μm. j Quantification of dsRED expression in co-transduced, BMP-7-treated or control slices over 7 days in alloxan-
exposed slices, showing no differences between groups. k Quantification of EGFP and co-localization of EGFP+ dsRED (yellow) in co-transduced alloxan-
exposed slices following treatment with BMP-7 (solid lines) or vehicle (dotted lines). Slices were challenged with alloxan a second time at d5, ablating new
insulin+ cells. Scale 500 µm. For a–k, n= 5 biologically independent samples from individual mice. Data are presented as mean ± SD. Each n further
represents the mean of three technical replicates, while plotted bars/lines are centered at mean. Source data are provided in the Source Data file.
ARTICLE NATURE COMMUNICATIONS | https://doi.org/10.1038/s41467-020-17040-8
8 NATURE COMMUNICATIONS |         (2020) 11:3265 | https://doi.org/10.1038/s41467-020-17040-8 | www.nature.com/naturecommunications












































































BMP-7 (EGFP + dsRED)




















































































































RIP Cre CMV dsRED STOP EGFP
LOXP LOXP
Time (days)
0 1 2 3 4 5 6 7
dsRED STOP EGFPCre CMVSHIP

























































1 2 3 4 5 6 70
Time (days)
8 9 10




































BMP-7 (EGFP + dsRED)
















BMP-7 (EGFP + dsRED)
Control (EGFP + dsRED)
EGFP signal
NATURE COMMUNICATIONS | https://doi.org/10.1038/s41467-020-17040-8 ARTICLE
NATURE COMMUNICATIONS |         (2020) 11:3265 | https://doi.org/10.1038/s41467-020-17040-8 |www.nature.com/naturecommunications 9
identity of the green cells, when alloxan was added again at this
point, all EGFP+ cells disappeared within 24 h (Fig. 4k).
Based on these results in mice, we sought to replicate this
adenoviral-based reporter system using HPSs. Slices were
generated from n= 5 donors and treated one day after
transduction with 100 ng/ml BMP-7 for 3 days, followed by
removal for 3 days (Fig. 5a–d). Since human β-cells are naturally
resistant to alloxan, pre-existing islets could not be eliminated as
previously done in murine slices. Therefore, co-transduction of
the two adenoviral vectors was expected to result in the labeling
of resident β-cells, whereas newly formed β-cells would represent
a comparatively smaller contribution to the overall EGFP signal.
Another prediction of the model was that, in the absence of
additional regeneration (i.e., no BMP-7 control), EGFP signal
corresponding exclusively to islets would plateau soon after all
transduced β-cells turned green. In contrast, BMP-7-mediated
formation of new insulin-producing cells would keep gradually
increasing in BMP-7-treated slices after controls have plateaued.
Confirming these hypotheses, EGFP signal in the BMP-7-treated
group continued to expand with time, whereas the islet-labeled
area in the control group remained unchanged after day 1
(Fig. 5c, d).
Since the insulin promoter used was not human, we set out to
confirm our findings using a synthetic human insulin promoter
(SHIP) with heightened specificity for human β-cells30 (kindly
provided by Dr. C. Brunicardi, University of Toledo, OH). Using
an adenovirus containing a SHIP-driven EGFP construct, we
tested for promoter specificity. As expected, we observed that all
SHIP-labeled cells were insulin+ (Fig. 5e and Supplementary
Fig. 5a, c, d), but not glucagon+ (Fig. 5e and Supplementary Fig.
5d), somatostatin+ (Supplementary Fig. 5b, d) or detected outside
islets (Supplementary Fig. 5e). Next, we co-transduced HPSs
(n= 3 donors), treated them with BMP-7 (or vehicle) for 3 days
and tracked β-cell formation over time. As before, following the
initial labeling of pre-existing islets in both groups (which is
delayed vs. that observed with RIP-Cre), we observed a
progressive increase of the EGFP-tagged area in the BMP-7-
treated group, whereas that of the control group remained largely
unchanged. The quantification of this signal showed significant
differences in total EGFP-expressing area at days 8–10 (4–6 days
after BMP-7 removal), confirming β-cell generation using a
human specific promoter system (Fig. 5g, h). Both with RIP and
SHIP, waves of yellow-tagged cells (Fig. 5c, h) were more readily
detected in BMP-7-treated slices than in controls.
Finally, we repeated the experiment using HPSs from a T2D
diabetic donor. While rarer, these samples present us with the
unique opportunity to study regeneration in a disease model. As
shown in Fig. 5i, j, these samples also exhibited BMP-7-
dependent increase of EGFP signal from day 8 onwards vs.
controls, suggesting that β-cells can be induced to regenerate in
slices from T2D donors.
Discussion
We describe here the long-term culture of HPSs using oxygen-
enhancing techniques. These methods resulted in the functional
preservation of endocrine and exocrine cells for at least 10 days,
a period during which HPSs cultured in control conditions
exhibited significant deterioration. The extended preservation of
organotypic pancreatic tissue, coupled with adenoviral-mediated
lineage tracing, offers a unique opportunity to explore human
endocrine regeneration in a culture setting that retains to a sig-
nificant degree the anatomical integrity of the native organ. While
previous reports have lineage-traced human primary pancreatic
tissue in vitro27,31–33, the very act of placing such tissues
in culture introduces experimental bias and induces artifactual
de-differentiation27,32,33. HPSs have circumvented those
problems3–7, but their usefulness has been limited to short-term
physiological studies due to their rapid degeneration. To our
knowledge, no other report on organotypic human pancreatic
tissues describes culture for longer than 48 h.
Suboptimal oxygenation is arguably the most critical factor
responsible for this loss of viability and function. The thickness of
HPSs (120 μm) is at the very limit of passive gas diffusion across
living tissue that would ensure survival of cells at its core, pro-
vided that an adequate oxygen supply (e.g., a blood vessel) existed
at both sides. This is not the case in regular settings, where air has
to diffuse through a much longer distance from the surface of the
medium to where the tissue is located—and then across it. Our
modeling confirms that anoxia occurs rapidly after only 16 h of
culture in transwells. Anoxia induces an irreversible loss of
respiratory capacity in the pancreas34. This leads not only to cell
death but, perhaps more importantly, a metabolic change in
the surviving cells, which adapt to lower environmental oxygen
by switching to glycolysis. Even though they still represent
an improvement over non-organotypic cultures, HPSs in
transwells are metabolically aberrant. In contrast, PFC-cultured
HPSs maintain low levels of lactate production and glucose
Fig. 5 Longitudinal tracking of β-cell formation in HPSs over extended culture. a Longitudinal red-green immunofluorescence imaging of HPSs
co-transduced with RIP-Cre and reporter adenoviruses (viral constructs in outline below). Scale 500 μm. b Quantification of dsRED expression in
co-transduced BMP-7- (solid red line) or vehicle- (dotted red line) treated slices over time, showing no significant differences between groups.
c Quantification of EGFP and co-localization of EGFP+ dsRED (yellow) in co-transduced HPSs following treatment with BMP-7 (solid lines) or vehicle
(dotted lines). Two-tailed t-test: *p-val5 days= 0.0363, **p-val6days= 0.0076, **p-val7days= 0.001. d Percentage of slice area expressing EGFP at d5, 6 and
7, as shown in c. Two-tailed t-test: *p-val5days= 0.0363, **p-val6days= 0.0076, **p-val6days= 0.0011. e Representative confocal immunofluorescence
imaging of a region of a slice containing islet-resident β-cells tagged by a SHIP-EGFP adenovirus. HPSs were transduced with the SHIP-EGFP adenovirus,
and slices were then fixed for immunostaining after 30 h. The lower row shows a magnified region for each channel of an islet with untagged α-cells (GCG,
Glucagon+), whereas some β-cells (insulin+) are tagged by SHIP-EGFP. Scale, top row, 200 μm; bottom, 50 μm. f Longitudinal immunofluorescence
imaging of HPSs co-transduced with SHIP-Cre and reporter adenoviruses (viral constructs in outline below). Scale 500 μm. g Quantification of dsRED
expression in co-transduced BMP-7- (solid red line) or vehicle- (dotted red line) treated slices over 10 days in human pancreatic slices, showing no
significant differences between groups. h Quantification of EGFP (green) and co-localization of EGFP+ dsRED (yellow) in co-transduced human slices
following treatment with BMP-7 (solid lines) or vehicle (dotted lines) over 10 days. For a–h, n= 3 biologically independent samples from individual donors
were used. Two-tailed t-test: *p-val8days= 0.0278, **p-val9days= 0.0237, **p-val10days= 0.0144. i Longitudinal red-green immunofluorescence imaging of
HPSs from a T2D donor co-transduced with SHIP-Cre and reporter adenoviruses (viral constructs in outline below panel) (n= 1 sample from an individual
donor). Scale 500 μm. j Quantification of EGFP and co-localization of EGFP+ dsRED (yellow) in co-transduced HPSs following treatment with BMP-7
(solid lines) or vehicle (dotted lines). The quantification of dsRED expression in co-transduced BMP-7- or vehicle-treated slices indicated no significant
differences between the two groups (n= 1). Two-tailed t-test: *p-val8days= 0.039, **p-val9days= 0.02. For b–d, g, h, and j data are presented as mean ± SD.
Each n further represents the mean of three technical replicates, while plotted bars/lines centered at mean. *p < 0.05; **p < 0.01; ***p < 0.005. Source data
are provided in the Source Data file.
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consumption rates after 10 days in culture. Since slices in
both groups produce comparable amounts of ATP, but the glu-
cose uptake and consumption are lower in those cultured in PFC,
our observations suggest the maintenance of a highly efficient,
oxidative phosphorylation-based metabolism. Additionally, PFC-
cultured HPSs displayed significantly better viability, cross-
sectional area, glucose responsiveness, and overall islet integrity
over the studied period. We speculate that this is due to the
suboptimal wellbeing of islets in control conditions35. Interest-
ingly, those improvements were more evident in the endocrine
than in the exocrine compartment. With the exception of the
cross-sectional area, which was significantly higher in the PFC
group, calcium imaging following exposure to acinar cell secre-
tagogues and overall IF profiles were largely comparable in both
groups at day 10. This may be due to refinements in the medium,
which contains two additional protease inhibitors (aprotinin and
chymostatin) compared to the formulations reported thus far for
HPSs1,9. Still, higher magnification images of the acinar com-
partment indicate more defined E-cadherin ultrastructure and
apical amylase granulation in PFC-cultured slices.
Another intriguing observation is that the acute dynamic glu-
cose response profile of HPSs immediately after sectioning was
worse than that recorded at day 10, be it on transwells or PFC
dishes. This prompted us to test whether resting the samples for
24 h after the stress of slicing would result in their functional
recovery, as it happens with islets after isolation22,23. This was
indeed the case, as shown in the second round of experiments
presented in Fig. 3g.
Our goal in refining the conditions for the long-term survival
of HPS was to allow for the real-time detection and quantification
of endocrine cell regeneration. Multiple models have been pre-
sented in the literature to explain β-cell regeneration, from β-cell
duplication36 and α-to-β cell transdifferentiation37,38 to ductal
progenitor cell differentiation (reviewed in ref. 39). We decided to
test the latter (ductal progenitors) owing to our previous dis-
covery of a BMP-7-responsive sub-population of progenitor-like
cells in the major ductal tree of the human pancreas27,28. How-
ever, our system could as easily be tailored to study other models
of regeneration37,38,40,41.
Proof-of-concept experiments were performed on a transgenic
mouse model that was first used to study β-cell neogenesis in
adult mice14. That report confirmed neogenesis during pancreatic
development and in newborn mice, but failed to detect yellow
(neogenic β-) cells after post-natal day 5 following a variety of
insults to the pancreas. However, we readily detected yellow cells
in slices derived from these very same mice after treatment with
BMP-7 and THR-123. This apparent contradiction is not such,
inasmuch as BMP-induced regeneration was not among the
models tested in that study. Notably, we were able to replicate this
in slices from non-transgenic mice, and subsequently from
humans, by means of adenoviral co-transduction of a red-green
reporter and an insulin lineage tracer. As predicted, the combi-
nation of long-term slice culture and virally-mediated lineage
tracing allowed us not only to detect, but to quantify BMP-7-
induced regeneration events longitudinally. The relatively low
frequency of co-transduction was not an obstacle to observe
transitional yellow and subsequently permanent green events in
HPSs, both with the rat insulin promoter (RIP) and with a human
synthetic insulin promoter (SHIP). Of note, owing to its mole-
cular design, the SHIP promoter could be potentially activated in
PDX1+ cells that do not express insulin30. However, we did not
observe such occurrence upon transduction of human pancreatic
slices with SHIP-Cre (Fig. 5e and Supplementary Fig. 5).
Although the relative percentage of green events was lower when
using the latter (suggesting a higher specificity of this promoter),
the differences were not statistically significant.
The increase in EGFP population is statistically significant in
the BMP-7 group vs. control. While the increase in the “yellow”
population (i.e., cells that are transiently both EGFP- and dsRED-
positive, reflecting new onset of insulin expression) is not statis-
tically significant, it is important to stress that, while green signal
is cumulative, yellow is not. Unlike the green signal, the yellow
that we detect at the time of imaging may or may not be repre-
sentative of what happens over a 24 h period. Therefore, deter-
mining true statistical significance based on the arbitrary
temporal measurement of cells that are yellow only for a short
period may not be possible.
An observation that stands out from the murine slice experi-
ments is that new green cells are also detected in controls (non-
BMP-7-treated), although at a significantly lower level. Both
groups were treated with a β-cell toxin (alloxan), which in itself is
a stimulus for regeneration42. This effect is likely aided by the
high concentration of BMPs present in the serum used to sup-
plement the murine (but not the human) culture medium43. In
HPSs, we did not detect any increase of EGFP signal in controls
after the initial tagging of pre-existing β-cells. In contrast, BMP-
7-treated slices displayed a time-dependent upward trend in
EGFP signal and significantly stronger waves of red-green co-
localization, suggesting additional formation of β-cells after the
initial labeling of the resident ones.
Importantly, our analyses are merely suggestive of β-cell neo-
genesis. The unequivocal demonstration of this phenomenon
would require additional lineage-tracing as well as endocrine cell
turnover determinations. Future work on such approaches will
shed additional light on these observations. In addition, owing to
the use of longitudinal slice-wide, low-magnification imaging
(which is necessary to address the uncertainty about the location
in the slice where new insulin+ cells may appear), transitional
events cannot be resolved at the single cell level. However, while
higher-resolution alternatives are developed, our analyses are still
valid to quantify overall fluorescence changes at the tissue level. It
must also be stressed that the in-depth mechanistic analysis of the
reported observations (e.g., the functional analysis of newly
formed insulin-producing cells) is beyond the scope of this report,
whose main focus is the description of a method for the long-
term, real-time monitoring of regeneration in live pancreatic
cultures that preserve the tissue cytoarchitecture and cell-to-cell
interactions of the native organ. This approach fills a void in the
field and will enable investigators to study regeneration in the
human pancreas with an unparalleled degree of resolution.
If applied to samples from T1D and T2D donors, long-term
cultured HPSs may offer new insights on the pathology—and
potential treatment—of diabetes.
Methods
COMSOL modeling-finite element modeling of oxygen distribution. 2D diffu-
sion reaction modeling of oxygen distribution within the pancreatic slices was
performed using COMSOL v5.3 (Comsol Inc, Burlington, MA)10,11. A parametric
sweep of oxygen consumption rates (1.0–5.0 × 10−2 mol/m3 s−1) unique to pan-
creatic tissue was performed15. The only conditions that differed between the two
culture models were the basal surface boundary condition with continuity utilized
for the transwell suspended in culture medium above the impermeable plastic
surface, and a concentration boundary at the basal surface of the oxygen sandwich
representative of the interface of the surface with the surrounding bulk oxygen. All
diffusivity was represented as diffusive permeability, the product of effective dif-
fusivity and the oxygen solubility in a given phase, in order to eliminate the need
for partition coefficients and to express the oxygen distribution in terms of partial
pressure (mmHg). Tissue anoxia was represented by a pO2 of <0.1 mmHg per
literature convention in regards to pancreatic islets and acinar tissue10,15–20.
Anoxic tissue volume was calculated as the ratio of pancreatic slice volume with a
pO2 < 0.1 mmHg to total pancreatic slice volume, assuming each slice was a
1–1.2 cm square.
Metabolic measurements. Medium samples were collected from each transwell or
PFC dish daily after the second medium change (12 h culture period) for the
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measurement of metabolic activity. Media analytes were measured on a Beckman
Coulter Vi-CELL MetaFLEX to determine glucose consumption, lactate production
and osmolarity of the media samples. At every measurement timepoint, a medium
blank was performed to normalize all pancreatic slice samples. In culture samples,
evaporation is a confounding factor, so all values were corrected using the relative
osmolarity of the culture sample relative to the media blank expressed in the
following equations for glucose consumption and lactate production:
GCR ¼
Gblank  ðGculture ´ OsmblankOsmcultureÞ
ΔTime
LPR ¼
ðLculture ´ OsmblankOsmcultureÞ  Lblank
ΔTime
All values for GCR were expressed as (µg consumed/produced per hour)/µg
DNA, while values for LPR were expressed as (µg produced/produced per hour)/
µg DNA.
Glucose uptake was measured as follows: slices were pre-incubated in glucose-
free BrainPhys medium (StemCell Technologies, Vancouver, BC, Cat# 05790)
containing 2% B27 supplement minus-insulin (Invitrogen, Carlsbad, CA; Cat#
A1895601) for 40 min. After washing 3X in PBS, slices from each group (PFC or
TW) were incubated for 10 min in regular BrainPhys medium (see composition
below) supplemented with 100 μM of 2-NBDG (Stemcell Technologies, Vancouver,
BC, Cat# 05790). After incubation, slices were immediately washed 10X in PBS;
briefly incubated with propidium iodide (PI), washed again 3×; briefly incubated
with DAPI, washed again 3×, and immediately imaged using a confocal
microscope.
DNA quantification of slice tissue. Pancreatic slices were digested using T-PER
Tissue protein extraction reagent (Invitrogen, Carlsbad, CA, Cat# 78510). Super-
natant was then used to calculate total DNA quantity using a Quant-iT Picogreen
dsDNA assay kit (Invitrogen, Carlsbad, CA, Cat# P7589) according to the man-
ufacturer’s recommendations.
Transgenic mouse models. All animal experiments were conducted under the
supervision and oversight of the University of Miami Institutional Animal Care
and Use Committee (IACUC) and Division of Veterinary Resources (DVR) at the
University of Miami. CD1-IGS mice (5–6 weeks old; Charles River, Wilmington,
MA, Cat# 022) were utilized for pancreatic tissue slicing to obtain control slices for
adenoviral transduction experiments. In order to create the INS2-Cre/mTmG
reporter, we crossed B6.Cg-Tg(Ins2-Cre)25Mgn/J (INS2-Cre; Jackson Labs, Bar
Harbor, ME, Cat# 003573) with B6.Gt(ROSA)26Sortm4(ACTB-tdTomato,-EGFP)Luo/J
(mTmG; Jackson Labs, Bar Harbor, ME, Cat# 007676). In the resulting mouse, all
insulin-producing cells (ventro-medial hypothalamus, pancreatic β- and δ-cells,
data not shown), express fluorescent EGFP, while all non-insulin-producing cells
express fluorescent tdTomato. We used only F1 generation mice for β-cell for-
mation experiments. Stability of the mTmG mouse was gauged by culturing
mTmG slices from both male and female mice. In addition, we also utilized the B6.
Cg-Tg(Ins1-EGFP)1Hara/J (Ins1-GFP; Jackson Labs, Bar Harbor, ME, Cat#
006864) mouse for confirming and tracking β-cell generation in pancreatic slices.
All mice were housed in specific pathogen-free (SPF) conditions at the DVR’s
animal care facility. For all experiments, mice were acclimated for 7–10 days prior
to any experimental intervention. They were maintained on a 12 h light/dark cycle
with ad libitum access to standard irradiated chow and filtered drinking water.
Pancreatic slicing and culture conditions. Tissue slicing: human pancreatic tissue
biopsies were obtained from the cGMP facility at the Diabetes Research Institute
(DRI), University of Miami, or as tissue/slices as part of the University of Florida
and nPOD’s human pancreatic tissue slice optimization initiative, the University of
Alberta (Canada) IsletCore and Prodo Labs (Aliso Viejo, CA), all from appro-
priately consented donors. A complete de-identified demographics table is pro-
vided in Supplementary table 1. Mouse and human pancreatic slices were generated
and processed as in1. Once cut, slices were washed with slice washing medium,
which contains DPBS (Sigma Aldrich, St. Louis, MO, Cat# D8537) supplemented
with 1X B27-minus Insulin (Invitrogen, Carlsbad, CA, Cat# A1895602), 1X
penicillin-streptomycin-amphotericin B solution (Sigma Aldrich, St. Louis, MO,
Cat# A5955), 100 µg/ml trypsin inhibitor from Glycine max (Sigma Aldrich, St.
Louis, MO, Cat# T6522), 10 µg/ml aprotinin (Sigma Aldrich, St. Louis, MO, Cat#
A6106), 10 µg/ml chymostatin (solubilized initially in DMSO; Sigma Aldrich, St.
Louis, MO, Cat# 11004638001), and 5.5 mM D-glucose (Sigma Aldrich, St. Louis,
MO, Cat# G8644). The addition of aprotinin and chymostatin was key to further
prevent the degradation and maintain the viability and function of slices long-term,
compared to earlier medium formulations for short-term studies1. Aprotinin
inhibits serine proteases including trypsin, chymotrypsin, plasmin and kallikrein.
Chymostatin is a strong inhibitor of chymotrypsin, papain, chymotrypsin-like
serine proteinases, chymases and lysosomal cysteine proteinases such as cathepsins
A, B, C, B, H, and L.
Dish coating: washed slices were placed atop 35 mm AirHive dishes (Biorep,
Miami, FL) with the help of curved blunt forceps. Each AirHive dish was pre-
coated with 250 µl collagen-fibronectin gel mixture. To prepare 1.6 ml of collagen-
fibronectin solution (enough for six AirHive dishes at 250 µl/dish), 2.4 mg
fibronectin (Sigma Aldrich, St. Louis, MO, Cat# F1141) was added to 720 ml of
DPBS for a 1.5 mg/ml final solution (it is suggested to make a master stock of the
protein solution at 3.3 mg/ml for easy use; Sigma Aldrich, St. Louis, MO, Cat#
D8537). 80 µl of 1 N NaOH (0.025 N final concentration; Sigma Aldrich, St. Louis,
MO, Cat# S2770) and 800 µl of ~3 mg/ml collagen type-I (1.5 mg/ml final solution;
Sigma Aldrich, St. Louis, MO, Cat# A10483-01) were added to the fibronectin
solution. Dishes were coated with 250 µl/unit, making sure that the entire surface
was covered by gently rotating the dish from side to side, and placement in a
humidified cell culture incubator at 37 °C for 45–90 min prior to usage. Once
coated, the dishes were carefully washed with ice-cold DPBS (Sigma Aldrich, St.
Louis, MO, Cat# D8537) 3X times.
Medium and culture conditions for murine slices: washed murine slices were
cultured using murine slice culture medium atop pre-coated AirHive dishes or
Corning Transwell® polyester membrane cell culture inserts (Corning, NY; Cat
#CLS3450-24EA) as controls. The formulation includes custom-made Waymouth’s
MB 752/1 medium (with L-glutamine; without D-glucose; Biological Industries,
Cromwell, CT, Cat# 06-1110-01-1 A) containing 11 mM D-Glucose (Sigma
Aldrich, St. Louis, MO, Cat# G8644), 1% heat-inactivated FBS (Invitrogen,
Carlsbad, CA, Cat# 16140063), 100 µg/ml trypsin inhibitor from Glycine max
(Sigma Aldrich, St. Louis, MO, Cat# T6522), 10 µg/ml aprotinin (Sigma Aldrich, St.
Louis, MO, Cat# A6106), 10 µg/ml chymostatin (solubilized initially in DMSO;
Sigma Aldrich, St. Louis, MO, Cat# 11004638001), and 1X penicillin-streptomycin-
amphotericin B solution (Sigma Aldrich, St. Louis, MO, Cat# A5955). Dishes
containing slices (maximum 3) and medium (maximum 1ml) were placed in a
humidified incubator at 37 °C for a maximum of 2 weeks. Medium changes were
made every 8–12 h.
Medium and culture conditions for human slices: HPSs were cultured using
human slice culture medium atop pre-coated AirHive dishes (coated similarly to
those for murine slices) or Corning Transwell® polyester membrane cell culture
inserts (Corning, NY; Cat #CLS3450-24EA) as controls. Human slice culture
medium contains basal BrainPhys neuronal medium (Stemcell Technologies,
Vancouver, BC, Cat# 05790) containing 2% B27 supplement minus-insulin
(Invitrogen, Carlsbad, CA, Cat# A1895601), 1% penicillin-Streptomycin-
Amphotericin B solution (Sigma Aldrich, St. Louis, MO, Cat# A5955), 1%
Glutamax supplement (Invitrogen, Carlsbad, CA, Cat# 35050061), L-Glutamic Acid
3.7 µg/ml (Sigma Aldrich, St. Louis, MO, Cat# 49449), 5.5 mM final D-glucose
concentration (of note, BrainPhys already contains 2.5 mM D-Glucose; Sigma
Aldrich, St. Louis, MO, Cat# G8644), 100 µg/ml trypsin inhibitor from Glycine max
(Sigma Aldrich, St. Louis, MO, Cat# T6522), 10 µg/ml aprotinin (Sigma Aldrich, St.
Louis, MO, Cat# A6106), 10 µg/ml chymostatin (solubilized initially in DMSO;
Sigma Aldrich, St. Louis, MO, Cat# 11004638001) and 1% HEPES buffer
(Invitrogen, Carlsbad, CA, Cat# 15630080). Dishes containing slices (maximum 3)
and medium (maximum 1ml) were placed in a humidified incubator at 30 °C for a
maximum of 2 weeks. Medium was changed every 8–12 h.
Adenoviral vectors. Recombinant adenoviruses were constructed using the ser-
otype 5 adenovirus with an E1/E3 deletion. A codon optimized Cre variant was
used. The Adv-RIP-Cre was created as in25. The SHIP was a gift from Dr. C.
Brunicardi (U. of Toledo, OH). The SHIP construct was cloned upstream of an
EGFP sequence to create the Adv-SHIP-EGFP adenovirus, and upstream of a
codon optimized Cre to create an Adv-SHIP-Cre adenovirus. The reporter con-
struct was a gift from Dr. P. Ravassard, Hôpital Pitié-Salpétrière-Paris, France, and
was loaded onto an adenoviral packaging plasmid to create the Adv-(CMV)-LoxP-
dsRED-STOP-loxP-EGFP adenoviral reporter. All adenoviral construction was
performed at Vector Biolabs, Malvern, PA. Slices were transduced with a MOI of
50 for the reporter and a MOI of 10 for SHIP-containing viruses.
Viability assessment. Pancreatic slices were incubated with calcein-AM to indi-
cate intracellular calcium activity (live cells) and ethidium homodimer-1 (dead
cells). Addition of both of these reagents was done according to the manufacturer’s
recommendations as part of the Live/Dead viability/cytotoxicity kit for mammalian
cells (Invitrogen, Carlsbad, CA, Cat# L3224). Once stained, slices were washed 3X
times with DPBS (Sigma Aldrich, St. Louis, MO, Cat# D8537) and fixed with 3.7%
paraformaldehyde. Fixed slices were counterstained with 1:400 4′, 6-diamidino-2-
phenylindole (DAPI) (Thermo Fisher/Life Technologies, Waltham, MA, Cat#
D1306) in DPBS (Sigma Aldrich, St. Louis, MO, Cat# D8537).
Dynamic glucose-stimulated insulin/glucagon release studies. Dynamic
glucose-stimulated insulin/glucagon release (perifusion) assays were performed
using pancreatic slices (3–4 slices per perifusion chamber in duplicates). Slices were
perifused within a perifusion chamber (Warner Instruments, Holliston, MA, Cat#
64-0223) put together using silicone grease (Warner Instruments, Holliston, MA,
Cat# 64-0378). The chamber rests on top of a chamber platform (Warner
Instruments, Holliston, MA, Cat# 64-0281). Perifusion was done in Krebs buffer
containing 125 mM NaCl, 5.9 mM KCl, 1.28 mM CaCl2, 1.2 mM MgCl2, 25 mM
HEPES, and 0.1% bovine serum albumin, pH 7.4 at 37 °C, using a PERI3 machine
with automated tray handling (Biorep Technologies, Miami, FL). Prior to loading
slices into the chamber, slices were incubated in Krebs buffer containing 3 mM
Glucose on a shaker set at 120 rpm at 37 °C, for 60–90 min. Slices were then loaded
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in the chamber using a fine brush of 2/0 size (Electron Microscopy Sciences, Hatfield,
PA, Cat# 66100-20) and connected to the perifusion system. Samples were challenged
with either low or high glucose (G1= 1mM; G3= 3mM; G16.7= 16.7mM) or
potassium chloride (KCl= 30mM) at a flow rate of 100 µL/min. After 90min of
flushing in G3 solution, slices were stimulated with the following sequence: 16min
G3, 20min G16.7, 30min G1, 5min G3+KCl, and 15min G3. Samples were col-
lected every 60 seconds into a 96-well plate kept at 4 °C, while the perifusion chamber
and perifusion solutions were maintained at 37 °C. After the perifusion, slices of one
chamber were fixed in 4% paraformaldehyde for 30min at room temperature and
stored in PBS at 4 °C for insulin staining and subsequent β-cell quantification. Slices
from the second chamber were placed in 500 µl of acid ethanol and stored at −20 °C.
Perfusates were aliquoted and stored at −20 °C. Insulin and glucagon levels were
determined using commercially available ELISA kits (Mercodia Inc., Winston Salem,
NC, Cat# 10-1113-01 for insulin and Crystal Chem, Elk Grove Village, IL, Cat# 81520
for glucagon) as per manufacturer’s recommendations with some modifications.
Perfusates above the standard curve of the assay were diluted (2×–4X times depending
on the secretion levels of the slice) to allow for quantification within the
sensitivity range.
Dynamic glucose-stimulated alpha-Amylase release studies. Pancreatic amy-
lase secretion was evaluated using 3X human pancreatic slices placed in a perifu-
sion chamber. Perifusion was similar to that described for glucose secretion, with
some modifications. Krebs buffer was supplemented with 10 µg/ml aprotinin
(Sigma Aldrich, St. Louis, MO, Cat# A6106), 3 mM D-glucose (Sigma Aldrich, St.
Louis, MO, Cat# G8644) and 1X penicillin-streptomycin-amphotericin B solution.
Slices were challenged with either 3 mM Glucose+ 10 pM Cholecystokinin 8
(Sigma Aldrich, St. Louis, MO, Cat# C2901), or 3 mM Glucose+ 10 µM Carbachol
(Sigma Aldrich, St. Louis, MO, Cat# 212385-M). Perifusates were collected after
every 120 s in a 96-well plate kept on ice at all times. Amylase quantity was
calculated using a calorimetric assay for amylase activity, based on the manu-
facturer’s recommendations (BioVision, Milpitas, CA, Cat# K711-100).
Quantification of cytosolic Ca2+ levels. Confocal images (pinhole= airy 1) of
randomly selected islets were acquired on a Leica SP5 confocal laser-scanning
microscope with 40× magnification (NA= 0.8). Pancreatic tissue slices were
reconstructed in Z-stacks of 15–30 confocal images (step size= 2.5–5.0 μm) and
analyzed using ImageJ. [Ca2+]i responses were quantified as the areas under the
curve of individual traces of Flou-4 fluorescence intensity during the application of
stimuli. Pancreatic tissue slices were bathed in Fluo-4 AM (2 μM) for 1 h. To
quantify changes in intracellular Ca2+ levels, we selected regions of interest around
individual endocrine cells and acinar cells. Fluorescence intensity was measured
using ImageJ. Changes in fluorescence intensity are expressed as percentage
changes over baseline (ΔF/F). We measured changes in total cytosolic Ca2+ levels
by computing the area under the curve above baseline using Prism software (Prism
7, GraphPad software, La Jolla, CA). Areas under the curve were determined
before, during, and after each stimulus for the same time period and compared
with statistical tests. For quantification of [Ca2+]i responses, we calculated the areas
under the curve of the fluorescence intensity traces of Fluo-4. Our criteria for
accepting [Ca2+]i responses for analyses were that: (1) responses could be elicited
≥2× by the same stimulus; and (2) the peak signal was ≥2 times the baseline
fluctuation. For quantification of β-cell responses, we selected cells that responded
to increases in [Ca2+]i during KCl and high glucose (16 mM) stimulation, in order
to exclude endocrine α-cells from our quantification.
Immunofluorescence analysis. Tissue slices were washed 2× for 5 min in 1X
phosphate buffered saline (PBS), pH 7.4 (Sigma Aldrich, St. Louis, MO, USA Cat#
P3813), and fixed in 3.7% paraformaldehyde solution overnight. Slices were then
washed 10X for 5 minutes in 1X phosphate buffered saline (PBS), pH 7.4 (Sigma
Aldrich, St. Louis, MO, USA Cat# P3813). Permeabilization was done for
30 minutes using 0.3% Triton (Sigma Aldrich, St. Louis, MO, USA Cat# T9284-
500ml) in 1X PBS, pH 7.4 (Sigma Aldrich, St. Louis, MO, USA Cat# P3813). After
this, slices were blocked with blocking buffer containing [dH2O, 5% normal donkey
serum (Jackson Labs, Bar Harbor, ME, Cat# H-400), 0.1% Triton and 1X power
block (Biogenex, San Ramon, CA, Cat# HK0855K)]. After 1 h, an additional
blocking step was done for 10 minutes with serum-free protein block (Dako, now
Agilent, Santa Clara, CA, Cat# X0909). Primary antibodies (see Supplementary
Table 2 for list of antibodies) were dissolved in the blocking buffer and incubated
for 48 h at 4 °C. Primary antibodies were then removed, and sections washed 7X for
5 min with 1X PBS, pH 7.4/0.1% Triton. Secondary antibody solutions (1:400) were
made with Alexa Fluor 488, 594 or 647 donkey anti-primary antibody species and
1:400 4′, 6-diamidino-2-phenylindole (DAPI) (Thermo Fisher/Life Technologies,
Waltham, MA, Cat# D1306) in blocking buffer. Samples were incubated with
secondary antibodies for 90 minutes and then washed 7× for 5 min with 1× PBS,
pH 7.4. To get the least amount of background fluorescence, an additional wash
was performed overnight at 4 °C with 1X PBS, pH 7.4. For imaging, slices were
transferred to 35 mm dishes containing a number-zero confocal grade crystal
(MatTek Corporation, Ashland, MA, Cat# P35G-0-10-C). Care was taken to ensure
slices were wet with DPBS/PBS at all times during confocal imaging (~100–150 µl
on top of the slices to prevent drying). Imaging during culture was performed using
an ApoTome Axiovert 200M (Zeiss) fluorescent microscope, with the slices posi-
tioned in similar orientations as the preceding day while atop the AirHive. End-
point imaging was performed using a Leica MP-NDD4/SP5/FCS/FLIM
multiphoton/confocal upright F-techniques microscope MP/SP5 having a laser set
at 30% intensity, pinhole set at 1, airy set at 1, with 10X and 20X magnification. Z-
stack depth ranged between 120 and 130 µm depending on the slice thickness and
condition, while the number of images in the Z-stack ranged between 15 and 25
with a step size ranging between 2.5 and 4 µm. To prevent bias, for eGFP/tdTomato
and viability studies we utilized ImageJ/FIJI to perform quantitative analysis of cell
populations, using total area calculations for fluorescent area and correlating to
brightfield slice area. In additional quantitation of images, DAPI-positive were
counted to determine the total number of cells, against which all the other markers
were quantified.
HIF1α determination. ELISA (MyBioSource #MBS2885065) was performed to
assess the levels of HNF1α comparing slices cultured in transwells and PFC. The
results were normalized to total tissue protein content using a PierceTM BCA assay
(Thermo Scientific #23227).
Quantitative real-time RT-PCR. qRT-PCR44 was performed with the Applied
Biosystems/Thermo Fisher Scientific (Waltham, MA) TaqMan® assays listed in the
Supplementary Data 1 (table of key resources).
Statistical analysis. Statistical analyses and graphing were performed using
GraphPad Prism v8 (GraphPad software, La Jolla, CA). Following the
Shapiro–Wilk normality test, statistical differences between groups were calculated
by two-tailed paired t test or Wilcoxon signed-rank test, with 95% confidence
intervals (∗p < 0.05; ∗∗p < 0.01; ∗∗∗p < 0.001). Results are expressed as mean ± SD.
Statistical comparisons for cytosolic Ca2+ levels were performed using Student’s
t test or one-way ANOVA followed by multiple-comparison procedures with the
Tukey or Dunnett’s tests. Data are shown as mean ± SEM.
Key resources. A table of key resources used in this manuscript is provided as
Supplementary Data 1.
Reporting summary. Further information on research design is available in
the Nature Research Reporting Summary linked to this article.
Data availability
All relevant data are available from the authors. Source data underlying Figs. 1e–g; 2d–g,
k; 3d–l, 4g–h, j–k; and 5b–d, g–h are provided as a Source data file.
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